About Prolistem (Azoospermia Treatment)


MedHija LLC is committed to innovation, research and effective problem-solving in the battle against male infertility, specializing in primary testicular failure.

The product of this extensive work on male fertility is Prolistem: the next generation of azoospermia treatment from SpermHope. Developed by Dr. Abuelhija in New York, specifically for azoospermic men, Prolistem is a new, all-natural treatment strategy that aims to prove azoospermia is a treatable condition.

Unlike existing treatments, Prolistem is based on a new understanding of testicular cell behavior which focuses on spermatogenesis (sperm production) and the mechanisms of hormonal actions. It offers an improved formula with higher potency to increase the possibility of promoting raised sperm counts among men who are experiencing non-obstructive azoospermia.

These encouraging breakthroughs mean new hope for non-obstructive azoospermia patients who have been told their condition is not treatable.

Prolistem is a trademark of Med-Hija LLC (DOS ID #:  4836543) (Patented Formula).


Dr. Abuelhija, M.

CEO & Founder

Dr Abuelhija

Dr. Abuelhija has been involved in male fertility studies since 2004, starting with the effect of cytokines and growth factors on the spermatogenesis in mice and humans, as well as in vitro cultures of germ cells and the effects of radiation on spermatogenesis recovery in rats. Dr. Abuelhija is the author and co-author of more than 15 scientific articles, abstracts, and book chapters and specializes in non-obstructive azoospermia.

Dr. Azab, M.

Genetic Scientist

Dr Abuelhija

Dr. Azab has a Long experience in genetic and molecular biology. He obtained a Ph.D. in genetics from Ben-Guerin University. Dr. Azab is a lab manager at private molecular genetic lab and he is a genetic consultant in our company.

Dr. Adawi, A.

Clinical Embryologist

Dr Abuelhija

Dr. Adawi has a Long experience in IVF and sperm analysis. He obtained a Ph.D. in microbiology and immunology from Ben-Guerin University. Dr. Adawi is a lab manager at private fertility lab and he is a fertility consultant in our company

Dr. Amash, A.
(Advisory Board Member)

Principal Scientist at Caprion Biosciences Inc.

Dr Abuelhija

Dr. Amash has a highly skilled medical science professional with a record of achievements developed over a rich combined 15-years of academic and pharmaceutical biomedical research in hematology, autoimmunity, immune-oncology and respiratory diseases. Exceptional ability to apply and leverage scientific and medical knowledge with commercial functionality.

Mr. Emmanuel Ochulayi
(Advisory Board Member)

CEO First Gate Clinic

Dr Abuelhija

Emmanuel Ochulayi has a Long experience in male and women fertility, he is a CEO First Gate Clinic and provides a wide range of services. He obtained the master degree of public health from the University of Roehampton.

Dr. Khaled Gadalla
(Advisory Board Member)

Consultant UroAndrologist, Integrative and Regenerative medicine Specialist

Dr Abuelhija

Dr. Khaled has a long experience in therapist with a demonstrated history of working in the hospital & health care industry. Skilled in Medical Tourism, Mindfulness, Oncology, Clinical Supervision, and Reproductive Health. Strong consulting professional with a Doctor of Philosophy – PhD focused in Clinical Sexology from American Academy of Clinical Sexologist.